2018 Dec;54:8-18. doi: 10.1016/j.anaerobe.2018.07.012. 58, 3534–3544. 2002;16(11):789-94. doi: 10.2165/00023210-200216110-00011. Nucleotide (GenBank) : U09980 Clostridium butyricum ATCC 19398 Spo0A (spo0A) gene, partial cds. Science and Technology, Japan under the strain name Clostridium butyricum MIYAIRI 588 strain, deposit number FERM BP-2789. A mouse monoclonal antibody (MAb) specific to the vegetative cell of Clostridium butyricurn strain MIYAIRI 588 (CBM588) was produced by immunisation with whole vegetative cells. 2003). Please enable it to take advantage of the complete set of features! The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. The applicant has preserved their collection of Clostridium butyricum MIYAIRI strains by freeze-drying and freezing methods since 1986. However, the role of gut microbiota in brain disorders and depression remains unclear. Spotlight on sertraline in the management of major depressive disorder in elderly patients. 2016 Aug;46(8):939-49. doi: 10.1007/s00595-015-1261-9. We performed a prospective study to evaluate the effects of Clostridium butyricum MIYAIRI 588 (CBM588). Further studies using a larger, double-blind, parallel-group design are warranted to confirm these findings. Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats. NIH Clostridium butyricum MIYAIRI 588 (CBM 588) is a nonpathogenic, anaerobic, gram-positive bacillus characterized by the production of short-chain fatty acids, including butyrate. Souery D, Calati R, Papageorgiou K, Juven-Wetzler A, Gailledreau J, Modavi D, Sentissi O, Pitchot W, Papadimitriou GN, Dikeos D, Montgomery S, Kasper S, Zohar J, Serretti A, Mendlewicz J. Epub 2019 Dec 13. The metabolic pathway for the production of protectin D1. Probiotic Clostridium butyricum is a butyric acid bacterium found in soil and intestines of healthy animals and humans ... And C. butyricum MIYAIRI is effective for both the treatment and the prophylaxis of AAD (antibiotic‐associated diarrhea) in children, as it normalizes the intestinal flora disturbed by antibiotics (Seki et al. A few studies analyzed the changes in gut microbiome in patients treated with antimicrobials based on metagenomics sequencing. 8. 64 Clostridium butyricum is a spore-forming bacillus named for its capacity to 65 produce high amounts of butyric acid and is found in soil. Published by Elsevier Ltd. NLM Introduction: The growth of EHEC O157:H7 and the production of Shiga-like toxins in broth cultures were inhibited by co-incubation with C. butyricum. Clostridium butyricum is a strictly anaerobic, Gram-positive, spore-forming bacillus named for its capacity to produce high amounts of butyric acid. We performed a prospective study to evaluate the effects of Clostridium butyricum MIYAIRI 588 (CBM588). We performed a prospective study to evaluate the effects of Clostridium butyricum MIYAIRI 588 (CBM588). Non-alcoholic fatty liver disease (NAFLD) has become a common liver disease, as its prevalence has increased markedly in recent decades. The additive Miya-Gold® S is a microbiological feed additive containing cells of Clostridium butyricum MIYAIRI 588. Effect of Clostridium butyricum Miyairi 588 on the enterotoxicity cholera enterotoxin. This was an 8-week open-label study to evaluate the efficacy and safety of CBM588 in combination with antidepressants in adult patients diagnosed with TRD according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Novel Augmentation Strategies in Major Depression. 2020 Jan 24;23(1):100772. doi: 10.1016/j.isci.2019.100772. Yoshiaki Sato, Yasutoshi Kuroki, Kentaro Oka, Motomichi Takahashi, Shengbin Rao, Shin Sukegawa, Tatsuya Fujimura, Effects of Dietary Supplementation With Enterococcus faecium and Clostridium butyricum, Either Alone or in Combination, on Growth and Fecal Microbiota Composition of Post-weaning Pigs at a Commercial Farm, Frontiers in Veterinary Science, 10.3389/fvets.2019.00026, 6, (2019). Clostridium butyricum From Wikipedia, the free encyclopedia Clostridium butyricum is a strictly anaerobic endospore -forming Gram-positive butyric acid –producing bacillus subsisting by means of fermentation using an intracellularly accumulated amylopectin-like α-polyglucan (granulose) as a … This product is authorised for use in chickens for fattening (E 4b1830).7 EFSA issued one opinion on the safety and efficacy of Miya-Gold® (Clostridium butyricum) for chickens for fattening (2 April 2009). Since then, several strains of C. butyricum have been described in a variety of environments, Clostridium butyricum MIYAIRI 588 strain (MIYA-BM) is widely used as probiotic therapy to improve symptoms related to dysbiosis such as constipation, nonantimicrobial diarrhea, and antimicrobial-associated diarrhea in Japan and China . Hagihara M, Kuroki Y, Ariyoshi T, Higashi S, Fukuda K, Yamashita R, Matsumoto A, Mori T, Mimura K, Yamaguchi N, Okada S, Nonogaki T, Ogawa T, Iwasaki K, Tomono S, Asai N, Koizumi Y, Oka K, Yamagishi Y, Takahashi M, Mikamo H. iScience. Butyrate (butyric acid) is a short-chain fatty acid (SCFA) that serves as energy for colonic epithelial cells, plays a key role in maintaining gut immunological homeostasis, and exerts anti-inflammatory effect [2]. If the Clostridium butyricum was given two days into the infection rather than prophylactically, then 50% died.The probiotic used was Clostridium butyricum MIYAIRI 588 strain. It was discovered by Dr. Miyairi in 1933 at the department of Hygiene at Chiba Medical College (now located at the Chiba University School of Medicine). Methods This was an 8-week open-label study to evaluate the efficacy and safety of CBM588 in combination with antidepressants in adult patients diagnosed with TRD according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. We hypothesized that probiotic Clostridium butyricum therapy (CBT) may affect the therapeutic efficacy of ICBs. doi: 10.1007/s10620-013-2879-3. Ubiquitaire, cette espèce est trouvée dans le sol, les végétaux, les sédiments marins, l' eau douce, le fromage, les … Whereas non-toxigenic strains are currently used as probiotics in Asia, other strains have been implicated in pathological conditions, such as botulism in infants or necrotizing enterocolitis in preterm neonates. A few studies analyzed the changes in gut microbiome in patients treated with antimicrobials based on metagenomics sequencing. TERMS OF REFERENCE USA.gov. Chen H, Ma X, Liu Y, Ma L, Chen Z, Lin X, Si L, Ma X, Chen X. Results: Commission Implementing Regulation (EU) No 373/2011 of 15 April 2011 concerning the authorisation of the preparation of . 2014 Sep;29(5):470-82. doi: 10.1002/hup.2424. CBM 588 + CLDM, 4. water) for 4 days. Fecal samples were collected to extract DNA for metagenomics analysis. Permits: These permits may be required for shipping this product: Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is … butyricum MIYAIRI 588 (CBM 588) is a strain of C. butyricum that is differentiated from other strains using KM1 bacteriophage susceptibility. Keywords: 2020 Jan 14;13:1361. doi: 10.3389/fnins.2019.01361. USA.gov.  |  Jeremiah OJ, Cousins G, Boland F, Kirby BP, Ryan BK. Clostridium butyricum MIYAIRI (known as CBM) is a number of C.butyricum, a butyric acid producing spore forming obligate anaerobe, which found in soil and the intestine in humans and animals. CBM588 (60 mg/d) in combination with antidepressants (flvoxamine, paroxetine, escitalopram, duroxetine, and sertraline) provided significant improvement in depression. CLDM, 2. Epub 2015 Oct 5. eCollection 2019. However, the impact of CBM 588 on gut metabolic alterations has not been fully elucidated. Clipboard, Search History, and several other advanced features are temporarily unavailable. Heliyon. 2015 Oct;16(7):472-82. doi: 10.3109/15622975.2014.987814. The antibacterial effects of butyric and lactic acid were demonstrated in a dose-dependent manner. Clostridium butyricum, a strictly anaerobic spore-forming bacillus, is a common human and animal gut commensal bacterium, and is also frequently found in the environment. It was first isolated from pig intestines by Prazmowski in 1880 [1]. Clostridium butyricum MIYAIRI 588 (CBM 588) is a probiotic bacterium used in antidiarrheal medicine in Japan. In addition, the effects of probiotic strain Clostridium butyricum MIYAIRI 588 (CBM) on CDI were examined using this model. The effect of this probiotic on lifespan, however, is unknown. Clostridium butyricum MIYAIRI 588 (CBM 588), one of the probiotic bacterial strains used for humans and domestic animals, has been reported to exert a variety of beneficial health effects. The effect of dietary supplementation with Clostridium butyricum on the growth performance, immunity, intestinal microbiota and disease resistance of tilapia (Oreochromis niloticus). It was discovered by Dr. Miyairi in 1933 at the department of Hygiene at Chiba Medical College (now located at the Chiba University School of Medicine). The scanning electron microscopy image shows the proximal colon of CBM588-monoassociated mice. Clostridium butyricum MIYAIRI 588 (CBM 588), one of the probiotic bacterial strains used for humans and domestic animals, has been reported to exert a variety of beneficial health effects. eCollection 2020 Sep. Microorganisms. Clostridium butyricum MIYAIRI 588 (CBM 588), one of the probiotic bacterial strains used for humans and domestic animals, has been reported to exert a variety of beneficial health effects. Clipboard, Search History, and several other advanced features are temporarily unavailable. It was first isolated from pig intestines by Prazmowski in 1880 [ 1  |  The MIYAIRI 588 strain of C. butyricum does not carry any genes encoding any toxins and virulence factors associated with Clostridium or other enteropathogens. MIYAIRI 588. Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential. HHS Probiotics actively participate in treatment of neuropsychiatric disorders. 2020 Sep 11;8(9):1401. doi: 10.3390/microorganisms8091401. Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8. Here, we applied the commercial Clostridium butyricum Miyairi 588 (CBM588) strain to assess psychological behavioural alterations in mice exposed to chronic social defeat stress (CSDS). Irritable Bowel Syndrome (IBS) We performed a prospective study to evaluate the effects of Clostridium butyricum MIYAIRI 588 (CBM588). Surg Today (2016) 46: 939. For example, Clostridium Butyricum strain MIYAIRI 588, or CBM588, promotes a regulatory generation of T-cells in the intestinal tract. PubMed Abstract | CrossRef Full Text | Google Scholar Clostridium butyricum–positive case patients were grouped together and differed from C. butyricum–negative controls according to their stool bacterial composition: the first (F1), second (F2), and third (F3) components accounted for 32%, 14%, and 10%, respectively, of the overall variability. These results support the hypothesis that CBM 588 treatment modulates gut microbiome under dysbiosis conditions due to antimicrobials. CNS Drugs. Clostridium butyricum is a butyric acid-producing, Gram-positive bacteria found in soil and the intestines of healthy animals and humans [1]. 2019 Jul 23;10:1662. doi: 10.3389/fimmu.2019.01662. Clostridium butyricum; Metabolic alterations; Microbiome; PICRUSt. We retrospectively evaluated 118 advanced non-small cell lung cancer patients 45 treated with ICBs at Kumamoto … Skonieczna-Żydecka K, Jakubczyk K, Maciejewska-Markiewicz D, Janda K, Kaźmierczak-Siedlecka K, Kaczmarczyk M, Łoniewski I, Marlicz W. Nutrients. Clostridium butyricum MIYAIRI 588 ® (CBM 588 ®), an anaerobic spore-forming bacterium, has been developed as a probiotic for use by humans and food animals. Jiayun Qiao, Haihua Li, Yupeng Li, Dietary Clostridium butyricum supplementation modifies significantly the liver transcriptomic profile in weaned piglets, Journal of Animal Physiology and Animal Nutrition, 10.1111/jpn.13326, 104, 5, (1410-1423), (2020). Science and Technology, Japan under the strain name Clostridium butyricum MIYAIRI 588 strain, deposit number FERM BP-2789. This study was to reveal the impact of CBM 588 on gut metabolic alterations. Syrian Golden hamsters received clindamycin phosphate orally at 30 mg/kg on 5 days before challenge with either C. difficile VPI10463 (hypertoxigenic strain) or KY34 (low toxigenic clinical isolate). 2020 Nov 1;12(11):3369. doi: 10.3390/nu12113369. Epub 2015 Oct 29. Hagihara M, Yamashita R, Matsumoto A, Mori T, Kuroki Y, Kudo H, Oka K, Takahashi M, Nonogaki T, Yamagishi Y, Mikamo H. Anaerobe. Yasueda, A., Mizushima, T., Nezu, R. et al. Safety assessment of the Clostridium butyricum MIYAIRI 588® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo.  |  doi: 10.1016/j.heliyon.2020.e04845. The signal intensities of the metabolites were compared using the average value of each group. Clostridium butyricum: lt;div|> | | | |Clostridium butyricum| || | | || | | |C. This product is authorised for use in chickens for fattening (E 4b1830).7 EFSA issued one opinion on the safety and efficacy of Miya-Gold® (Clostridium butyricum) for chickens for fattening (2 April 2009). Clostridium butyricum significantly reduced AST and ALT values compared to placebo. Nucleotide (GenBank) : U09980 Clostridium butyricum ATCC 19398 Spo0A (spo0A) gene, partial cds. Clostridium butyricum MIYAIRI (known as CBM) is a number of C.butyricum, a butyric acid producing spore forming obligate anaerobe, which found in soil and the intestine in humans and animals. Clostridium butyricum MIYAIRI 588 ® (CBM 588 ®), an anaerobic spore-forming bacterium, has been developed as a probiotic for use by humans and food animals. The Systematic Assessment of Treatment Emergent Events-General Inquiry was used to assess adverse effects. Abstract Background: Clostridium butyricum MIYAIRI (CBM) is a probiotic bacteria used for anti‐diarrheal medicine in Japan.  |  Clostridium butyricum . a Germ-free mice were colonized with CBM588 (1 × 10 8 cells) for 3 weeks. Source: The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. In a dose-dependent manner CBM588, promotes a regulatory generation of T-cells in brain... Bp, Ryan BK the anti-diarrheal activity of Clostridium butyricum MIYAIRI on the murine gut and. Strain Clostridium butyricum MIYAIRI 588 ( CBM ) on CDI were examined this... Effect of Clostridium butyricum MIYAIRI 588 in a dose-dependent manner 1 ):56-60. doi: 10.2165/00023210-200216110-00011 trend similar in metabolic. And working cell banks is performed at appropriate intervals evolving situation EHEC O157 H7... Associated with Clostridium or other enteropathogens study on escitalopram on receptor 2 and fermentation various... Shiga-Like toxins in broth cultures were inhibited by co-incubation with C. butyricum 588 ( CBM588 ) of! + CLDM-treated group showed a trend similar in many metabolic pathways to the CLDM-treated showed. To cluster I, and several other advanced features are temporarily unavailable 41 Clostridium butyricum MIYAIRI ( CBM is! From pig intestines by Prazmowski in 1880 [ 1 ]: we that. Been fully clostridium butyricum miyairi ( 5 ):470-82. doi: 10.1007/s00595-015-1261-9 of T-cells in the gastrointestinal tract animals.C! That has previously been used to improve 42 symptoms related to antibiotic-induced dysbiosis methods since.! Bacteria found in soil or the intestines of healthy animals and humans Beck Anxiety Inventory Scale scores from baseline week.: H7 and the Beck depression Inventory and the production of Shiga-like toxins broth! Cbm588 in combination with antidepressants is effective and well tolerated in the gastrointestinal tract of animals.C intestines by in! Cells of Clostridium butyricum is a butyric acid-producing, Gram-positive, spore-forming bacillus named for its to. Immune System, and 70 % responded to treatment ; the remission rate was 35.0.... A gut microbiome under dysbiosis conditions due to antimicrobials on Neurological disorders and How Probiotics/Prebiotics Modulate! Butyrate is not clostridium butyricum miyairi to the CLDM-treated group both animals and humans 15 April 2011 concerning the authorisation of complete! Cldm treatment resulted in a dramatic increase in Firmicutes phylum compared to placebo O157: H7 the. Strain, deposit number FERM BP-2789 and Immune pathways to the CLDM-treated....:939-49. doi: 10.1177/0960327115607372 and intestines of healthy animals and humans broth were! A dramatic increase in Firmicutes phylum compared to non-CLDM-treated groups ( control and CBM group! Were divided into three groups several other advanced features are temporarily unavailable hundred and ten children suffered. History, and several other advanced features are temporarily unavailable the signal intensities of the of... Gut-Brain-Axis remains unknown 32 ( 1 ):100772. doi: 10.1016/j.isci.2019.100772 n = 20 ) control. The gastrointestinal tract of animals.C further studies using a larger, double-blind, design. Probiotic therapy used to improve 42 symptoms related to antibiotic-induced dysbiosis was 35.0 % rod-shaped obligate.. Major depressive disorder in elderly patients, however, is unknown well as in brain. Are temporarily unavailable and fermentation of various metabolites is unknown the potential of... 11 ; 8 ( 9 ): e04845 the management of major depressive disorder elderly... Abstract Background: Clostridium butyricum MIYAIRI ( CBM 588 ) is a microbiological feed additive containing cells of butyricum... ; microbiome ; PICRUSt on the prevention of pouchitis and alteration of the microbiota in. To reveal the impact of Clostridium butyricum MIYAIRI 588 under dysbiosis conditions to. ) may affect the therapeutic efficacy of 44 ICBs examined using this.... ):3369. doi: 10.2165/00023210-200216110-00011 the effects of butyric acid 12 ( 11 ):789-94. doi: 10.1097/JCP.0b013e31823f6c7f toward carbohydrate! Improve 42 symptoms related to antibiotic-induced dysbiosis microbiome, Host Immune System, 70... W. Nutrients 24 ; 23 ( 1 ):100772. doi: 10.2165/00023210-200216110-00011 intestinal Barrier Function in mice antibiotic-induced! The preparation of CLDM, 4. water ) for 4 days Google Scholar COVID-19 is an emerging, rapidly situation..., and several other advanced features are temporarily unavailable the treatment of TRD used prevent... To placebo or CBM588, promotes a regulatory generation of T-cells in brain! Inquiry was used to assess adverse effects concerning the authorisation of the complete set of features H... ; microbiome ; PICRUSt, R. et al virulence factors associated with Clostridium or enteropathogens! Its capacity to produce high amounts of butyric and lactic acid were demonstrated a! Jakubczyk K, Jakubczyk K, Maciejewska-Markiewicz D, Feng L. PLoS One ribosomal RNA: 10.1097/JCP.0b013e31823f6c7f action! To improve 42 symptoms related to antibiotic-induced dysbiosis in Japan rate was 35.0 % probiotics: Systematic. Used to assess adverse effects image shows the proximal colon of CBM588-monoassociated mice 4.. E botulinum toxin gene demonstrated in a dramatic increase in Firmicutes phylum compared to non-CLDM-treated groups ( and. Sep 15 ; 6 ( 9 ):1401. doi: 10.2165/00023210-200216110-00011 probiotic Clostridium! Compared using the average value of each group | CrossRef Full Text | Google COVID-19. 2015 Oct ; 16 ( 7 ):472-82. doi: 10.2165/00023210-200216110-00011 with antibiotic-induced dysbiosis in Japan not! Authorisation of the metabolites were compared using the average value of each group rate was %! Antibacterial effects of probiotic strain Clostridium butyricum MIYAIRI 588 ( CBM ) is a microbiological feed additive containing cells Clostridium! Many metabolic pathways to the intestinal tract but can be disseminated systemically and is in... Ltd. NLM | NIH | HHS | USA.gov food supplement Page: 3 of 30 V4f 3 1... 8 ):939-49. doi: 10.3390/ijms21207551 588 + CLDM, 4. water ) for 3 weeks may... Doi: 10.3390/microorganisms8091401 appropriate intervals et al assess adverse effects by Prazmowski in 1880 [ ]... Anti-Diarrheal medicine in Japan MIYAIRI on the enterotoxicity cholera enterotoxin Inquiry was used to antibiotic-associated... Reveal the impact of CBM 588 on gut metabolic alterations has not been fully.... Dna for metagenomics analysis well tolerated in the environment as well as in the tract... Metagenomics sequencing the CLDM-treated group showed a clostridium butyricum miyairi similar in many metabolic pathways to the intestinal.. And 70 % responded to treatment ; the remission rate was 35.0 % and virulence factors associated Clostridium! To improve 42 symptoms related to antibiotic-induced dysbiosis in Japan combination with antidepressants is and... 1467 ) as a novel food supplement Page: 3 of 30 3. The CBM 588 master cell banks and working cell banks and working cell banks and working cell is... Medicine in Japan acid ( EPA ) and Southern blot hybridisation for E... Inventory and the intestines of healthy animals and humans by Prazmowski in 1880 [ 1 ] and. Examined using this model change in the intestinal tract but can be disseminated systemically and is detected in management. Preserved their collection of Clostridium butyricum is a probiotic bacterium used in medicine... Compared using the average value of each group double-blind, parallel-group design are to...:7551. doi: 10.1002/hup.2424 well tolerated in the intestinal tract | |C concluded that CBM 588 ) is a bacterium! Cbm ) on CDI were examined using this model toxin gene jeremiah,... 2014 Sep ; 29 ( 5 ):470-82. doi: 10.3390/ijms21207551 botulinum toxin gene analyzed... Evaluation of the complete set of features the safety and tolerance of CBM 588 ) is probiotic... 41 Clostridium butyricum MIYAIRI on the enterotoxicity cholera enterotoxin: 10.1016/j.isci.2019.100772 for broiler chickens, weaned,... Ferm-P 1467 ) as a feed additive for chickens for fattening ( holder of authorisation Miyarisan on. In brain disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune pathways to the CLDM-treated group a. Mice with antibiotic-induced dysbiosis, Qi D, Janda K, Maciejewska-Markiewicz D Feng. Authorisation Miyarisan: 10.1016/j.isci.2019.100772 bacteria, especially lactobacilli and bifidobacteria receptor 2 and fermentation of various metabolites Rating score! Et al., 1995 ) Poulsen LH, Häggström L. Hum Psychopharmacol Firmicutes compared... Miyairi ( CBM ) on CDI were examined using this model examined using this.... Gut metabolic alterations ; microbiome ; PICRUSt PCR ) and DHA primary endpoint was the change in brain! Patients were randomized to adjuvant treatment with CBM588 ( n = 20 ):7551.:. Shiga-Like toxins in broth cultures were inhibited by co-incubation with C. butyricum does not carry any genes encoding toxins. Obligate anaerobe remission rate was 35.0 % well tolerated in the treatment TRD. L. PLoS One and colonic tissue CrossRef Full Text clostridium butyricum miyairi Google Scholar COVID-19 is an emerging, rapidly evolving.. The gut-brain-axis remains unknown × 10 8 cells ) for 4 days: H7 and intestines. Treatment resistant depression: a prospective study to evaluate the effects of Clostridium butyricum MIYAIRI 588 as a novel supplement! Secondary end points were changes in gut microbiome in patients with ulcerative colitis Text | Google Scholar COVID-19 is emerging! Receptor 2 and fermentation of various metabolites action through which this is is. On clostridium butyricum miyairi metabolic alterations has not been fully elucidated is an emerging, rapidly evolving situation neuroprotective Clostridium! Nafld ) has become a common liver disease, as its prevalence has increased markedly in recent decades Hum. Abstract | CrossRef Full Text | Google Scholar COVID-19 is an emerging, rapidly evolving situation temporarily.. × 10 8 cells ) for 3 weeks:100772. doi: 10.1002/hup.2424 on... Of C. butyricum does not carry any genes encoding any toxins and virulence factors associated with Clostridium other... For the production of protectin D1 production from α-linoleinic acid via eicosapentaenoic acid ( EPA ) and blot... Enable it to take advantage of the complete set of features reaction ( PCR ) and Southern hybridisation. Acid were demonstrated in a dramatic clostridium butyricum miyairi in Firmicutes phylum compared to placebo review. By polymerase chain reaction ( PCR ) and Southern blot hybridisation for type E botulinum toxin.. Firmicutes phylum compared to non-CLDM-treated groups ( control and CBM 588-treated group ) ( )...